International Cannabis Expansion Gives Tilray Positive 2026 Outlook

Core Insights - Tilray (TLRY) reported improved financial performance for Q2-2026, with increased revenues and a reduced net loss, primarily driven by international cannabis sales [1] Financial Performance - Revenues increased significantly, contributing to the overall improvement in financial health [1] - The net loss showed improvement, indicating better cost management and operational efficiency [1] Market Strategy - Tilray reaffirmed its commitment to entering the US cannabis market, contingent upon rescheduling regulations [1]